Bone regeneration response in an experimental long bone defect orthotopically implanted with alginate‐pullulan‐glass‐ceramic composite scaffolds. Issue 3 (9th August 2019)

• Record Type: Journal Article
• Authors: Popescu, Radu A.; Tăbăran, Flaviu A.; Bogdan, Sidonia; Fărcăṣanu, Alexandru; Purdoiu, Robert; Magyari, Klara; Vulpoi, Adriana; Dreancă, Alexandra; Sevastre, Bogdan; Simon, Simion; Papuc, Ionel; Baia, Lucian
• Is Part Of: Journal of biomedical materials research. Volume 108:Issue 3(2020)
• Page Start: 1129
• Page End: 1140
• Publication Date: 2019-08-09
• Subjects: angiogenesis -- bone formation -- in vivo -- MRI; Biomedical materials -- Periodicals; 610.28
• DOI: 10.1002/jbm.b.34464
• Languages: English
• ISSNs: 1552-4973

Abstract

Abstract: In the present study, scaffolds based on alginate‐pullulan‐bioactive glass‐ceramic with 0.5 and 1.5 mol % copper oxide were orthotopically implanted in experimental rat models to assess their ability to heal an induced bone defect. By implying magnetic resonance and imaging scans together with histological evaluation of the processed samples, a progressive healing of bone was observed within 5 weeks. Furthermore, as the regenerative process continued, new bone tissue was formed, enhancing the growth of irregular bone spicules around the scaffolds. A significantly higher amount of new bone was formed (37%) in the defect that received the composite with 1.5 mol % CuO (in glass‐ceramic matrix) content implant. Nevertheless, the bone regeneration obtained by scaffold with 0.5 mol % CuO implanted is comparable with the alginate‐pullulan‐β‐tricalcium phosphate/hydroxiapatite composite implant. The assessed amount of new bone formed was found to be between 29.75 and 37.15% for all the composition involved in the present study. During this process a regeneration process was shown when the alginate‐pullulan composite materials were involved, fact that indicate the great potential of these materials to be used in tissue engineering. Abstract :